心碎:在血液性恶性瘤中检测和预防心脏毒性
Azin Vakilpour1, Bénédicte Lefebvre2, Catherine Lai3
1Division of Cardiovascular Diseases, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Blood reviews
|January 5, 2024
概括
血液癌症患者因治疗而面临高心力衰竭风险. 对心血管毒性的早期检测和干预对于改善存活率和预防治疗延迟至关重要.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 心脏瘤学 - 心脏瘤学
背景情况:
- 血液性恶性瘤显著增加心血管 (CV) 发病率和死亡率,特别是心力衰竭.
- 对这些恶性瘤的传统癌症治疗通常会导致急性和长期的心血管毒性.
- 心血管毒性风险受患者因素和治疗特点 (类型,剂量,持续时间) 的影响.
研究的目的:
- 审查血液恶性瘤常规治疗的心血管效应.
- 详细说明常见心血管毒性的发生率和定义.
- 概述指南推的心血管毒性早期检测和预防策略.
主要方法:
- 文献综述,重点关注血液癌症疗法的心血管影响.
- 分析常见心血管毒性的定义和发病率.
- 目前关于早期检测和预防心血管毒性的指导方针的综合.
主要成果:
- 传统的血液癌症治疗方法具有相当大的心血管毒性风险.
- 早期诊断和干预是缓解心血管不良事件的关键.
- 积极的心脏监测和及时管理可以改善患者的预后和治疗坚持.
结论:
- 心血管毒性是血液癌症治疗中的一个主要问题.
- 实施早期检测,监测和预防策略可以显著降低心血管风险.
- 优化CV护理对于改善癌症幸存者的治疗结果至关重要.
相关概念视频
Bone Marrow Sampling and Transplants
333
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
333
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Heart Failure Drugs: Inotropic Agents
591
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
591
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
160
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
160
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K


